RE: Price forecast15 Oct 2024 15:15
12p - 20 bagger, yes that would do nicely DCraig...
Quite possible should we get a positive outcome from the SRI collab work. Not to mention the Liptide FDA status and the IBD oral progress.
Commercial interest from a third party would be preferable from me at this stage to hopefully provide a catalyst. Nigel stated the following in the 25th Apr collab rns (and the SRI work to date has been successful), I quote straight from the horses mouth:
"We are delighted to be working with SRI and to have entered into this collaboration agreement. Combining our technologies successfully WILL lead to working with major pharma companies in the fields of oncology and vaccines with the exciting potential to develop novel products."